Viola Medical Services Limited 09203647 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is medical services Digita Accounts Production Advanced 6.30.9574.0 true true 09203647 2024-04-01 2025-03-31 09203647 2025-03-31 09203647 bus:OrdinaryShareClass1 2025-03-31 09203647 bus:OrdinaryShareClass2 2025-03-31 09203647 core:RetainedEarningsAccumulatedLosses 2025-03-31 09203647 core:ShareCapital 2025-03-31 09203647 core:CurrentFinancialInstruments 2025-03-31 09203647 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09203647 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 09203647 core:FurnitureFittingsToolsEquipment 2025-03-31 09203647 core:MotorVehicles 2025-03-31 09203647 bus:SmallEntities 2024-04-01 2025-03-31 09203647 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09203647 bus:FilletedAccounts 2024-04-01 2025-03-31 09203647 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09203647 bus:RegisteredOffice 2024-04-01 2025-03-31 09203647 bus:Director1 2024-04-01 2025-03-31 09203647 bus:Director2 2024-04-01 2025-03-31 09203647 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 09203647 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 09203647 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09203647 bus:Agent1 2024-04-01 2025-03-31 09203647 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 09203647 core:MotorVehicles 2024-04-01 2025-03-31 09203647 core:OfficeEquipment 2024-04-01 2025-03-31 09203647 countries:England 2024-04-01 2025-03-31 09203647 2024-03-31 09203647 core:FurnitureFittingsToolsEquipment 2024-03-31 09203647 core:MotorVehicles 2024-03-31 09203647 2023-04-01 2024-03-31 09203647 2024-03-31 09203647 bus:OrdinaryShareClass1 2024-03-31 09203647 bus:OrdinaryShareClass2 2024-03-31 09203647 core:RetainedEarningsAccumulatedLosses 2024-03-31 09203647 core:ShareCapital 2024-03-31 09203647 core:CurrentFinancialInstruments 2024-03-31 09203647 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 09203647 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 09203647 core:FurnitureFittingsToolsEquipment 2024-03-31 09203647 core:MotorVehicles 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09203647

Viola Medical Services Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Viola Medical Services Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 9

 

Viola Medical Services Limited

Company Information

Directors

Dr F Bayshev

N Bushueva

Registered office

Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

Accountants

MMO Limited
Chartered Accountants
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Viola Medical Services Limited
for the Year Ended 31 March 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Viola Medical Services Limited for the year ended 31 March 2025 as set out on pages 3 to 9 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Viola Medical Services Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Viola Medical Services Limited and state those matters that we have agreed to state to the Board of Directors of Viola Medical Services Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Viola Medical Services Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Viola Medical Services Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Viola Medical Services Limited. You consider that Viola Medical Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Viola Medical Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

MMO Limited
Chartered Accountants
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN

28 August 2025

 

Viola Medical Services Limited

(Registration number: 09203647)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

43,801

56,453

Current assets

 

Debtors

5

37,858

33,819

Cash at bank and in hand

 

12,685

8,604

 

50,543

42,423

Creditors: Amounts falling due within one year

6

(15,019)

(12,505)

Net current assets

 

35,524

29,918

Total assets less current liabilities

 

79,325

86,371

Creditors: Amounts falling due after more than one year

6

(27,622)

(33,306)

Provisions for liabilities

(8,322)

(10,726)

Net assets

 

43,381

42,339

Capital and reserves

 

Called up share capital

7

200

200

Retained earnings

43,181

42,139

Shareholders' funds

 

43,381

42,339

 

Viola Medical Services Limited

(Registration number: 09203647)
Balance Sheet as at 31 March 2025

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 22 August 2025 and signed on its behalf by:
 

.........................................
Dr F Bayshev
Director

 

Viola Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Wellesley House
204 London Road
Waterlooville
Hampshire
PO7 7AN
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

All figures are presented in British Sterling, which is the functional currency of the company, and are rounded to the nearest £1.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Government grants

Government grants relating to revenue expenditure are recognised in income over the periods in which the entity recognises the related costs for which the grant is intended to compensate.

 

Viola Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25%- written down value

Motor vehicles

25%- written down value

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Viola Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

 

Viola Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 April 2024

15,557

51,990

67,547

Additions

1,949

-

1,949

At 31 March 2025

17,506

51,990

69,496

Depreciation

At 1 April 2024

10,011

1,083

11,094

Charge for the year

1,874

12,727

14,601

At 31 March 2025

11,885

13,810

25,695

Carrying amount

At 31 March 2025

5,621

38,180

43,801

At 31 March 2024

5,546

50,907

56,453

5

Debtors

Current

2025
£

2024
£

Trade debtors

37,858

33,819

 

37,858

33,819

 

Viola Medical Services Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

6

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

5,684

5,684

Taxation and social security

 

5,370

2,502

Accruals and deferred income

 

505

505

Other creditors

 

3,460

3,814

 

15,019

12,505

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

27,622

33,306

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

Ordinary A shares of £1 each

100

100

100

100

200

200

200

200